This on demand session explores how to maintain momentum in population PK modeling without compromising quality. See how Phoenix NLME and RsNLME support scalable and manageable workflows as project demands evolve. The focus is on continuity, helping teams adapt to changing requirements while delivering consistent, high quality results.
Session highlights
Target mediated drug disposition
Kathleen Koeck, PhD
Director, Certara Drug Development Solutions
Compartmental population PK for a CNS therapy
Nathalie Gosselin, PhD
Vice President, Certara Drug Development Solutions
Ideal for:
- Quantitative Clinical Pharmacologists
- Early career pharmacometricians
